Blue Jet Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Blue Jet Healthcare reported FY26 revenue of ₹10,299.85 million, up 5.8% from ₹9,732.1 million in FY25. Profit after tax grew 23.1% to ₹3,052.03 million from ₹2,478.16 million, with EPS of ₹17.59 vs ₹14.29 year earlier. The Board recommended a final dividend of ₹1.2 per share (60% payout). The company also proposed raising up to ₹10,000 million through QIP, preferential issue, or private placement. Capital work in progress increased significantly to ₹3,013.76 million from ₹888.84 million, indicating major expansion. Statutory auditors KKC & Associates issued an unmodified opinion with no qualifications.
Strong profit growth and clean audit support a positive outlook; however, the large proposed fund raise could dilute shareholder value. The significant expansion in capital work-in-progress suggests major capacity investments underway.